Pushing Back with Pills — Enhancing Access to Reproductive Health Drugs after Dobbs
- 22 September 2022
- journal article
- editorial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 387 (12), 1056-1058
- https://doi.org/10.1056/nejmp2209377
Abstract
Drugs (and therefore drug regulation) will play a critical role in the future of reproductive rights, and the FDA and prochoice state legislators could take steps to facilitate access to key products.Keywords
This publication has 3 references indexed in Scilit:
- Now is the time to safeguard access to emergency contraception as abortion restrictions sweep the United StatesContraception, 2022
- A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counterContraception, 2022
- Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort studyBJOG: An International Journal of Obstetrics and Gynaecology, 2021